These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7129295)

  • 41. Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients.
    Walker C; Essex MN; Li C; Park PW
    J Int Med Res; 2016 Jun; 44(3):483-95. PubMed ID: 26980340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
    Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W
    Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity.
    Calin A; Nakache JP; Gueguen A; Zeidler H; Mielants H; Dougados M
    J Rheumatol; 1999 Apr; 26(4):975-9. PubMed ID: 10229431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
    Barkhuizen A; Steinfeld S; Robbins J; West C; Coombs J; Zwillich S
    J Rheumatol; 2006 Sep; 33(9):1805-12. PubMed ID: 16960941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Double-blind trial of the therapeutic efficacy of voltaren and indomethacin in Bechterew's disease].
    Burdeĭnyĭ AP
    Ter Arkh; 1981; 53(7):107-11. PubMed ID: 7027508
    [No Abstract]   [Full Text] [Related]  

  • 46. Tolerability and efficacy of a slow-release indomethacin tablet in ankylosing spondylitis.
    Lehtinen K; Kaarela K; Mäkisara P; Holttinen K; Gordin A
    Br J Rheumatol; 1984 Feb; 23(1):52-6. PubMed ID: 6365231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms.
    Di Rienzo Businco L; Di Rienzo Businco A; D'Emilia M; Lauriello M; Coen Tirelli G
    Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):279-83. PubMed ID: 15871609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of fatigue in the management of patients with ankylosing spondylitis.
    Dernis-Labous E; Messow M; Dougados M
    Rheumatology (Oxford); 2003 Dec; 42(12):1523-8. PubMed ID: 13130145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Slow release diclofenac sodium (Voltaren) in soft tissue rheumatism-a multicentre trial.
    Jaffer NA
    J Pak Med Assoc; 1983 Apr; 33(4):95-9. PubMed ID: 6410092
    [No Abstract]   [Full Text] [Related]  

  • 50. [Intravenous high dose glucocorticoids in patients with ankylosing spondylitis].
    Rumiantseva OA; Bochkova AG; Liginova EIu; Kiseleva NM; Pushkova OV; Bunchuk NV
    Ter Arkh; 2006; 78(12):71-5. PubMed ID: 17294868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Flexibilization of infliximab dose interval in the treatment of ankylosing spondylitis].
    Vinagre F; Santos MJ; Silva JC
    Acta Reumatol Port; 2007; 32(3):271-3. PubMed ID: 17940497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis--a randomized study.
    Widberg K; Karimi H; Hafström I
    Clin Rehabil; 2009 Jul; 23(7):599-608. PubMed ID: 19403551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of a quantitative scoring of enthesitis in ankylosing spondylitis.
    Kaya A; Ozgocmen S; Kamanli A; Aydogan R; Yildirim A; Ardicoglu O
    J Clin Rheumatol; 2007 Dec; 13(6):303-6. PubMed ID: 18176136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
    Baraliakos X; Brandt J; Listing J; Haibel H; Sörensen H; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2005 Dec; 53(6):856-63. PubMed ID: 16342093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks.
    Haibel H; Rudwaleit M; Listing J; Sieper J
    Ann Rheum Dis; 2005 Feb; 64(2):296-8. PubMed ID: 15208175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Activity of diclofenac after a single, evening administration as compared with naproxen, in ambulatory patients with rheumatoid arthritis].
    Caruso I; De Candia O; Frizziero L; Loizzi P; Mattara L; Riente L; Trombetta N; Cornelli U
    Clin Ter; 1981 Sep; 98(5):525-34. PubMed ID: 7030583
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cortisonoid sparing with the aid of sodium diclofenac in the treatment of rheumatoid arthritis].
    Loos-Vranić V
    Reumatizam; 1980; 27(5):150-6. PubMed ID: 7006027
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of diclofenac in ankylosing spondylitis.
    Calabro JJ
    Am J Med; 1986 Apr; 80(4B):58-63. PubMed ID: 3518435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Multicenter study on the use of injectable diclofenac in pain states: analysis of the clinical data on 1873 patients].
    Baroni L; Grossi E; Trombetta N
    Clin Ter; 1983 Sep; 106(6):447-56. PubMed ID: 6641106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.